系统性硬化症血管病变研究进展

doi:10.3969/j.issn.1004-583X.2021.03.019

摘要/Abstract

摘要：

系统性硬化症(systemic sclerosis, SSc)是一种以血管病变及纤维化为主要临床特征结缔组织病,较为少见但病死率高,疾病进展具有异质性。血管病变可促进纤维化形成,其程度与病情相关。部分学者认为重要脏器如心、肺、肾受累可能由血管病变导致,目前血管形态改变与功能变化间的相互关系尚不明确。随着辅助手段的改进,血管病变评估可能帮助SSc的早期诊断、预后判断以及疗效评价。本文就近期SSc血管病变相关探讨作一综述。

关键词: 硬皮病, 系统性, 血管疾病, 纤维化, 结果评价(卫生保健)

中图分类号:

R593.2

陈可欣, 杨敏. 系统性硬化症血管病变研究进展[J]. 临床荟萃, 2021, 36(3): 281-284.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2021.03.019

https://huicui.hebmu.edu.cn/CN/Y2021/V36/I3/281

参考文献 40

[1]	Allanore Y, Distler O, Matucci-Cerinic M, et al. Review: Defining a unified vascular phenotype in systemic sclerosis[J]. Arthritis Rheumatol, 2018,70(2):162-170. doi: 10.1002/art.40377 URL
[2]	Di Benedetto P, Ruscitti P, Liakouli V, et al. The vessels contribute to fibrosis in systemic sclerosis[J]. Isr Med Assoc J, 2019,21(7):471-474. pmid: 31507123
[3]	Zhang Y, Shen L, Zhu H, et al. PGC-1α regulates autophagy to promote fibroblast activation and tissue fibrosis[J]. Ann Rheum Dis, 2020,79(9):1227-1233. doi: 10.1136/annrheumdis-2020-216963 URL
[4]	Didier K, Giusti D, Le Jan S, et al. Neutrophil extracellular traps generation relates with early stage and vascular complications in systemic sclerosis[J]. J Clin Med, 2020,9(7):2136. doi: 10.3390/jcm9072136 URL
[5]	Leffler J, Stojanovich L, Shoenfeld Y, et al. Degradation of neutrophil extracellular traps is decreased in patients with antiphospholipid syndrome[J]. Clin Exp Rheumatol, 2014,32(1):66-70.
[6]	Chrysanthopoulou A, Mitroulis I, Apostolidou E, et al. Neutrophil extracellular traps promote differentiation and function of fibroblasts[J]. J Pathol, 2014,233(3):294-307. doi: 10.1002/path.4359 URL
[7]	Takahashi T, Asano Y, Amiya E, et al. Clinical correlation of brachial artery flow-mediated dilation in patients with systemic sclerosis[J]. Modern Rheumatol, 2014,24(1):106-111. doi: 10.3109/14397595.2013.854064 URL
[8]	Aïssou L, Meune C, Avouac J, et al. Small, medium but not large arteries are involved in digital ulcers associated with systemic sclerosis[J]. Joint Bone Spine, 2016,83(4):444-447. doi: 10.1016/j.jbspin.2015.09.003 pmid: 26750764
[9]	Soulaidopoulos S, Pagkopoulou E, Katsiki N, et al. Arterial stiffness correlates with progressive nailfold capillary microscopic changes in systemic sclerosis: results from a cross-sectional study[J]. Arthritis Res Ther, 2019,21(1):253. doi: 10.1186/s13075-019-2051-3 URL
[10]	Bieber A, Dolnikov K, Chizik V, et al. Microangiopathy and forearm arterial blood flow in systemic sclerosis: a controlled study[J]. Clin Rheumatol, 2020,39(9):2671-2676. doi: 10.1007/s10067-020-05025-3 URL
[11]	Domsic RT, Dezfulian C, Shoushtari A, et al. Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemic sclerosis patients[J]. Clin Exp Rheumatol, 2014, 32(6 Suppl 86):S-154-160.
[12]	Hashimoto T, Satoh T, Yokozeki H. Toe gangrene associated with macroangiopathy in systemic sclerosis: a case series on the unreliability of the ankle-brachial pressure index[J]. Acta Derm Venereol, 2018,98(5):532-533. doi: 10.2340/00015555-2897 URL
[13]	Sulli A, Secchi M E, Pizzorni C, et al. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients[J]. Ann Rheum Dis, 2008,67(6):885-887. doi: 10.1136/ard.2007.079756 URL
[14]	Sulli A, Paolino S, Pizzorni C, et al. Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: A 12 year study[J]. Rheumatology (Oxford), 2020,59(5):1051-1058. doi: 10.1093/rheumatology/kez374 pmid: 31750929
[15]	Ruaro B, Pizzorni C, Paolino S, et al. Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients[J]. Microvasc Res, 2019,125:103874. doi: 10.1016/j.mvr.2019.04.004 URL
[16]	Avouac J, Lepri G, Smith V, et al. Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis[J]. Semin Arthritis Rheum, 2017,47(1):86-94. doi: 10.1016/j.semarthrit.2017.02.006 URL
[17]	Pavan TR, Bredemeier M, Hax V, et al. Capillary loss on nailfold capillary microscopy is associated with mortality in systemic sclerosis[J]. Clin Rheumatol, 2018,37(2):475-481. doi: 10.1007/s10067-017-3869-1 URL
[18]	Caetano J, Paula FS, Amaral M, et al. Nailfold videocapillaroscopy changes are associated with the presence and severity of systemic sclerosis-related interstitial lung disease[J]. J Clin Rheumatol, 2019,25(3):e12-e15. doi: 10.1097/RHU.0000000000000815 pmid: WOS:000463385200003
[19]	Dinsdale G, Moore T, O'Leary N, et al. Quantitative outcome measures for systemic sclerosis-related microangiopathy - reliability of image acquisition in nailfold capillaroscopy[J]. Microvasc Res, 2017,113:56-59. doi: 10.1016/j.mvr.2017.05.003 URL
[20]	Mihai C, Smith V, Dobrota R, et al. The emerging application of semi-quantitative and quantitative capillaroscopy in systemic sclerosis[J]. Microvasc Res, 2018,118:113-120. doi: 10.1016/j.mvr.2018.03.004 URL
[21]	Berks M, Dinsdale G, Murray A, et al. Automated structure and flow measurement - a promising tool in nailfold capillaroscopy[J]. Microvasc Res, 2018,118:173-177. doi: 10.1016/j.mvr.2018.03.016 URL
[22]	Bulkley BH, Ridolfi RL, Salyer WR, et al. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction[J]. Circulation, 1976,53(3):483-490. pmid: 1248080
[23]	Mizuno R, Fujimoto S, Saito Y, et al. Cardiac Raynaud's phenomenon induced by cold provocation as a predictor of long-term left ventricular dysfunction and remodelling in systemic sclerosis: 7-year follow-up study[J]. Eur J Heart Fail, 2010,12(3):268-275. doi: 10.1093/eurjhf/hfp198 URL
[24]	Rodriguez-Reyna TS, Morelos-Guzman M, Hernandez-Reyes P, et al. Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography[J]. Rheumatology (Oxford), 2015,54(4):647-654. doi: 10.1093/rheumatology/keu350 URL
[25]	Colaci M, Giuggioli D, Spinella A, et al. Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: A cross-sectional study[J]. Clin Rheumatol, 2019,38(6):1637-1642. doi: 10.1007/s10067-019-04427-2 URL
[26]	Colaci M, Dal Bosco Y, Schinocca C, et al. Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients[J]. Clin Rheumatol, 2020, Jun 6. [Online ahead of print]
[27]	Zanatta E, Famoso G, Boscain F, et al. Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: A newsworthy association[J]. Autoimmun Rev, 2019,18(2):177-183. doi: 10.1016/j.autrev.2018.09.002 URL
[28]	Faccini A, Agricola E, Oppizzi M, et al. Coronary microvascular dysfunction in asymptomatic patients affected by systemic sclerosis-limited vs. diffuse form[J]. Circ J, 2015,79(4):825-829. doi: 10.1253/circj.CJ-14-1114 URL
[29]	Condliffe R, Howard LS. Connective tissue disease-associated pulmonary arterial hypertension[J]. F1000Prime Rep, 2015,7:6.
[30]	Yamakawa H, Takemura T, Iwasawa T, et al. Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?[J]. BMC Pulm Medi, 2018,18(1):25.
[31]	Champtiaux N, Cottin V, Chassagnon G, et al. Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality[J]. Semin Arthritis Rheum, 2019,49(1):98-104. doi: 10.1016/j.semarthrit.2018.10.011 URL
[32]	Gigante A, Romaniello A, Magrì D, et al. Correlation between intrarenal arterial stiffness and exercise tolerance in systemic sclerosis patients without renal and cardiopulmonary impairment: the role of the microvascular damage[J]. Int J Cardiol, 2015,185:122-124. doi: 10.1016/j.ijcard.2015.03.089 URL
[33]	Zhai Z, Staring M, Ninaber MK, et al. Pulmonary vascular morphology associated with gas exchange in systemic sclerosis without lung fibrosis[J]. J Thorac Imaging, 2019,34(6):373-379. doi: 10.1097/RTI.0000000000000395 URL
[34]	Yamashita H, Kamei R, Kaneko H. Classifications of scleroderma renal crisis and reconsideration of its pathophysiology[J]. Rheumatology (Oxford), 2019,58(12):2099-2106. doi: 10.1093/rheumatology/kez435 pmid: 31566243
[35]	Gigante A, Barbano B, Gasperini ML, et al. Renal parenchymal thickness in patients with systemic sclerosis is related to intrarenal hemodynamic variables and raynaud renal phenomenon[J]. J Rheumatol, 2020,47(4):567-571.
[36]	Gigante A, Bruni C, Lepri G, et al. The renal resistive index: a new biomarker for the follow up of vascular modifications in systemic sclerosis[J]. J Rheumatol, 2020, April 1;jrheum.191101 [Online ahead of print]
[37]	Bruni C, Rosato E, Maestripieri V, et al. The renal resistive index in systemic sclerosis: determinants, prognostic implication and proposal for specific age-adjusted cut-offs[J]. Eur J Intern Med, 2019,70:43-49. doi: 10.1016/j.ejim.2019.09.001 URL
[38]	Lescoat A, Yelnik CM, Coiffier G, et al. Ulnar artery occlusion and severity markers of vasculopathy in systemic sclerosis: a multicenter cross-sectional study[J]. Arthritis Rheumatol, 2019,71(6):983-990. doi: 10.1002/art.40799 pmid: WOS:000470986800018
[39]	Rosato E, Barbano B, Gigante A, et al. Doppler ultrasound study of penis in men with systemic sclerosis: A correlation with Doppler indices of renal and digital arteries[J]. Int J Immunopathol Pharmacol, 2013,26(4):1007-1011. pmid: 24355239
[40]	Motegi SI, Sekiguchi A, Yonemoto Y, et al. Demographic and clinical characteristics of spinal calcinosis in systemic sclerosis: Possible association with peripheral angiopathy[J]. J Dermatol, 2019,46(1):33-36. doi: 10.1111/jde.2019.46.issue-1 URL

系统性硬化症血管病变研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 40

相关文章 15

编辑推荐

Metrics

本文评价

[1]	顾天舒, 梁雪, 蔡嘉庚, 李广平. m6A RNA甲基化修饰在心血管疾病中的进展[J]. 临床荟萃, 2023, 38(8): 743-748.
[2]	熊璐, 郭莲. 胰岛素样生长因子-1及其结合蛋白与非酒精性脂肪性肝病发生发展的研究进展[J]. 临床荟萃, 2023, 38(10): 935-939.
[3]	王宁, 李勇. 簇集蛋白在心血管疾病中的研究进展[J]. 临床荟萃, 2022, 37(9): 842-845.
[4]	张怡, 崔晓冉, 杨晓红. 单核细胞/高密度脂蛋白胆固醇比值在心血管疾病中研究进展[J]. 临床荟萃, 2022, 37(6): 551-555.
[5]	张磊, 娄海东, 智昱, 亓树莹. PCSK9抑制剂对动脉粥样硬化性心血管疾病有效性及安全性的meta分析[J]. 临床荟萃, 2022, 37(12): 1074-1080.
[6]	杨瑞, 刘宇宏. 类风湿关节炎患者血脂水平与心血管疾病风险相关研究进展[J]. 临床荟萃, 2022, 37(1): 92-96.
[7]	叶蒙蒙, 李旎, 徐国栋, 邵国丰. miR-361在心血管疾病的研究进展[J]. 临床荟萃, 2021, 36(9): 843-849.
[8]	吴军来, 柴克霞. TAM/Gas6通路及其与临床疾病的关系[J]. 临床荟萃, 2021, 36(7): 664-668.
[9]	卢昊阳, 卢家忠, 韩明锋, 吕新才, 张标, 戎成振, 贾蕾蕾, 潘强强, 马蕾蕾, 赵韧. 新型冠状病毒肺炎合并心血管疾病的临床治疗观察[J]. 临床荟萃, 2021, 36(3): 203-207.
[10]	简郭进, 张斌. 沙库巴曲缬沙坦在心血管疾病中的研究进展[J]. 临床荟萃, 2021, 36(11): 1041-1045.
[11]	梁欢1，刘建凤2. 盘点钠-葡萄糖协同转运蛋白2抑制剂临床研究新进展[J]. 临床荟萃, 2020, 35(9): 861-864.
[12]	年士艳a，冯磊b. 云南省元江县傣族、哈尼族和彝族心血管病相关生化指标的差异性研究[J]. 临床荟萃, 2020, 35(8): 689-692.
[13]	原倩1，刘福珍2，朱西琪2. 脑小血管病的研究进展[J]. 临床荟萃, 2020, 35(5): 462-465.
[14]	刘晓腾a, 张英a, 金凤表b, 刘慧卿a, 高宇b, 李青联a, 侯瑞田a. 成纤维细胞生长因子21在糖脂代谢及心血管疾病中的研究进展[J]. 临床荟萃, 2020, 35(5): 472-475.
[15]	杨华, 孟利民, 信栓力, 常超, 赵秀峰, 王民. 心房颤动患者血清趋化素水平与心房纤维化程度的相关性[J]. 临床荟萃, 2020, 35(3): 206-210.